Andrés F. Muro, ICGEB, Mouse Molecular Genetics, Group Leader Trieste -  ITALY speaks on "Crigler-Najjar Syndrome type I_ new insights into disease mechanisms and therapy using Ugt1 knock-out mice". This seminar has been recorded at ICTP Trieste by ICGEB Trieste

Andrés F. Muro, ICGEB, Mouse Molecular Genetics, Group Leader Trieste - ITALY speaks on "Crigler-Najjar Syndrome type I_ new insights into disease mechanisms and therapy using Ugt1 knock-out mice". This seminar has been recorded at ICTP Trieste by ICGEB Trieste

A. Muro - Crigler-Najjar Syndrome type I_ new insights into disease mechanisms and therapy using Ugt1 knock-out mice

ICGEB annual course held in Trieste, Italy, covering topics including basic principles of mouse genetics, mutagenesis approaches, archiving, phenotyping, informatics and databases, quantitative traits, examples of disease model discovery and the use of mouse disease models as a therapeutic tool. (Artwork G. Bortolussi ICGEB Lab. Skeletal muscle fibers transduced with AAV vector expressing green fluorescent protein (eGFP). Nuclei are stained in blue (Hoechst).

Share A. Muro - Crigler-Najjar Syndrome type I_ new insights into disease mechanisms and therapy using Ugt1 knock-out mice

Sign up to save your podcasts

A. Muro - Crigler-Najjar Syndrome type I_ new insights into disease mechanisms and therapy using Ugt1 knock-out mice

A. Muro - Crigler-Najjar Syndrome type I_ new insights into disease mechanisms and therapy using Ugt1 knock-out mice